News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
233,080 Results
Type
Article (5265)
Company Profile (24)
Press Release (227791)
Multimedia
Podcasts (3)
Webinars (4)
Section
Business (82439)
Career Advice (465)
Deals (15092)
Drug Delivery (8)
Drug Development (19316)
Employer Resources (30)
FDA (3706)
Job Trends (3934)
News (120624)
Policy (7577)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (301)
Accelerated approval (7)
Adcomms (4)
Allergies (14)
Alliances (14857)
ALS (38)
Alzheimer's disease (295)
Antibody-drug conjugate (ADC) (47)
Approvals (3817)
Artificial intelligence (86)
Autoimmune disease (30)
Automation (6)
Bankruptcy (97)
Best Places to Work (2888)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (108)
Cancer (955)
Cardiovascular disease (62)
Career advice (397)
Career pathing (3)
CAR-T (65)
CDC (2)
Cell therapy (169)
Cervical cancer (5)
Clinical research (16945)
Collaboration (373)
Compensation (388)
Complete response letters (8)
COVID-19 (335)
CRISPR (13)
C-suite (349)
Cystic fibrosis (28)
Data (1396)
Denatured (2)
Depression (21)
Diabetes (87)
Diagnostics (2127)
Digital health (11)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (34)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (37)
Earnings (42869)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39335)
Executive appointments (434)
FDA (4466)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (345)
Gene editing (24)
Generative AI (7)
Gene therapy (104)
GLP-1 (156)
Government (439)
Guidances (198)
Healthcare (5062)
HIV (11)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (43)
Immuno-oncology (11)
Indications (19)
Infectious disease (363)
Inflammatory bowel disease (37)
Inflation Reduction Act (3)
Influenza (8)
Intellectual property (33)
Interviews (54)
IPO (7897)
IRA (3)
Job creations (1126)
Job search strategy (363)
JPM (5)
Kidney cancer (10)
Labor market (10)
Layoffs (109)
Leadership (5)
Legal (2342)
Liver cancer (21)
Longevity (2)
Lung cancer (108)
Lymphoma (79)
Machine learning (3)
Management (10)
Manufacturing (143)
MASH (52)
Medical device (3921)
Medtech (3931)
Mergers & acquisitions (7606)
Metabolic disorders (233)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (542)
NextGen: Class of 2026 (1681)
Non-profit (738)
Now hiring (5)
Obesity (91)
Opinion (35)
Ovarian cancer (30)
Pain (26)
Pancreatic cancer (41)
Parkinson's disease (50)
Partnered (6)
Patents (53)
Patient recruitment (103)
Peanut (6)
People (25314)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (5090)
Phase 2 (7344)
Phase 3 (5909)
Pipeline (2040)
Policy (18)
Postmarket research (626)
Preclinical (1958)
Press Release (66)
Prostate cancer (58)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (185)
Real estate (1890)
Recruiting (8)
Regulatory (5634)
Reports (17)
Research institute (310)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (50)
Series A (53)
Series B (57)
Sickle cell disease (11)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1024)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (82)
Venture capital (10)
Weight loss (33)
Women's health (6)
Date
Today (7)
Last 7 days (183)
Last 30 days (560)
Last 365 days (9025)
2026 (991)
2025 (9168)
2024 (11129)
2023 (13239)
2022 (18732)
2021 (19820)
2020 (18383)
2019 (13275)
2018 (10233)
2017 (10054)
2016 (9190)
2015 (12132)
2014 (9594)
2013 (7709)
2012 (8334)
2011 (8801)
2010 (8637)
Location
Africa (188)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (12076)
Australia (1692)
California (3667)
Canada (1155)
China (240)
Colorado (145)
Connecticut (165)
Delaware (138)
Europe (25619)
Florida (550)
Georgia (67)
Idaho (24)
Illinois (165)
India (17)
Indiana (114)
Iowa (9)
Japan (172)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (354)
Massachusetts (2851)
Michigan (104)
Minnesota (203)
Mississippi (1)
Missouri (33)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1033)
New Mexico (5)
New York (839)
North Carolina (485)
North Dakota (4)
Northern California (1962)
Ohio (117)
Oklahoma (5)
Oregon (6)
Pennsylvania (607)
Puerto Rico (2)
Rhode Island (19)
South America (280)
South Carolina (17)
Southern California (1319)
Tennessee (63)
Texas (491)
United States (12666)
Utah (111)
Virginia (85)
Washington D.C. (17)
Washington State (299)
West Virginia (2)
Wisconsin (60)
Wyoming (1)
233,080 Results for "incyte corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Incyte Reports Fourth Quarter and Full Year 2025 Financial Results
February 10, 2026
·
19 min read
Press Releases
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results
January 28, 2026
·
1 min read
Press Releases
Incyte Announces Change to its Board of Directors
December 15, 2025
·
1 min read
Press Releases
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema
November 7, 2025
·
13 min read
Press Releases
Incyte to Present at Upcoming Investor Conference - December 18, 2025
December 19, 2025
·
1 min read
Press Releases
Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
December 8, 2025
·
6 min read
Press Releases
Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel
December 2, 2025
·
3 min read
Press Releases
Incyte to Present at Upcoming December 2025 Investor Conferences
November 20, 2025
·
1 min read
Press Releases
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
February 1, 2026
·
8 min read
Press Releases
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer
December 23, 2025
·
7 min read
1 of 23,308
Next
